TRIM16 and breast cancer: First, TRIM16 can enhance the transcription of retinoic acid receptor β (RARβ), and overexpression of TRIM16 significantly reduces the proliferation of RA-sensitive NB cells as well as RA-resistant lung and breast cancer cells [42].